孕期糖尿病:与孕产妇和新生儿并发症的关联
Rebecca Karkia1, Tara Giacchino1, Saadia Shah2
1Medway Fetal and Maternal Medicine Centre, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK.
Medicina (Kaunas, Lithuania)
|December 23, 2023
概括
孕期糖尿病 (GDM) 增加了母亲和新生儿并发症,如早产和NICU入院,即使严格管理. 然而,GDM并没有增加死胎或新生儿死亡的风险.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 新生儿科学 新生儿科学
背景情况:
- 孕期糖尿病 (GDM) 与妊娠并发症有关,但最近关于其强度的证据有限.
- 严格的GDM管理指南在多学科环境中需要更新的协会数据.
研究的目的:
- 在GDM怀孕中比较并发症率与先前存在的糖尿病和非糖尿病怀孕.
- 使用调整的几率比率,量化GDM与妊娠并发症的独立关联.
主要方法:
- 预期队列研究 (2010年1月 - 2022年6月) 在英国产科.
- 包括在11-13周怀孕时预订的单独怀孕.
- 多变量回归分析以调整混因素并评估风险 (异常比率,95% CI).
主要成果:
- GDM独立地预测了母亲的不良结果:早产,多水,孕前,孕期新生儿大,和可选的剖腹产.
- 独立预测GDM新生儿不良后果:新生儿集中治疗室入院,低血糖症,黄和呼吸困扰综合征.
- 与GDM相关的死产,缺氧缺血性脑病变或新生儿死亡风险没有增加.
结论:
- 孕期糖尿病与显著增加特定孕产妇和新生儿并发症的发生率有关.
- 这些关联甚至在调整母亲和怀孕特征后仍然存在.
- 孕期糖尿病并不会增加死产,缺氧缺血性脑病变或新生儿死亡的风险.
相关概念视频
Pathophysiology of Diabetes
944
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
944
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
553
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
553
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
207
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
207


